Deborah Raymond
Overview
Explore the profile of Deborah Raymond including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1473
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoo A, Wise A, Ortega R, Raymond D, Plitnick B, Brons J, et al.
Parkinsonism Relat Disord
. 2024 Oct;
129:107149.
PMID: 39405632
Importance: Sleep disturbances in Parkinson's disease (PD) are common and often adversely affect quality of life. Light therapy has benefited sleep quality and mood outcomes in various populations but results...
2.
Laabs B, Lohmann K, Vollstedt E, Reinberger T, Nuxoll L, Kilic-Berkmen G, et al.
Mov Disord
. 2024 Sep;
39(11):2110-2116.
PMID: 39287592
Background: Despite considerable heritability, previous smaller genome-wide association studies (GWASs) have not identified any robust genetic risk factors for isolated dystonia. Objective: The objective of this study was to perform...
3.
Wise A, Ortega R, Raymond D, Cervera A, Thorn E, Leaver K, et al.
Front Neurol
. 2024 Aug;
15:1450654.
PMID: 39175765
Background: variants have been associated with immune dysregulation as well as immune-related disorders such as IBD. A possible relationship between multiple sclerosis (MS) and PD has also been suggested. Further,...
4.
Navarro E, Efthymiou A, Parks M, Riboldi G, Vialle R, Udine E, et al.
bioRxiv
. 2024 Jun;
PMID: 38854101
The G2019S mutation in the leucine-rich repeat kinase 2 (LRRK2) gene is a major risk factor for the development of Parkinson's disease (PD). LRRK2, although ubiquitously expressed, is highly abundant...
5.
Miltenberger-Miltenyi G, Ortega R, Domingo A, Yadav R, Nishiyama A, Raymond D, et al.
NPJ Parkinsons Dis
. 2023 Dec;
9(1):160.
PMID: 38062033
There is a paucity of genetic characterization in people with Parkinson's disease (PD) of Latino and Afro-Caribbean descent. Screening LRRK2 and GBA variants in 32 New Yorkers of Puerto Rican...
6.
Pal G, Cook L, Schulze J, Verbrugge J, Alcalay R, Merello M, et al.
Mov Disord
. 2023 Jun;
38(8):1384-1396.
PMID: 37365908
Genetic testing for persons with Parkinson's disease is becoming increasingly common. Significant gains have been made regarding genetic testing methods, and testing is becoming more readily available in clinical, research,...
7.
Saunders-Pullman R, Raymond D, Ortega R, Shalash A, Gatto E, Salari M, et al.
Mov Disord
. 2023 Jun;
38(8):1527-1535.
PMID: 37310233
Background: There is growing clinical and research utilization of genetic testing in Parkinson's disease (PD), including direct-to-consumer testing. Objectives: The aim is to determine the international landscape of genetic testing...
8.
Ortega R, Bressman S, Raymond D, Ozelius L, Wang C, Bennett S, et al.
Mov Disord
. 2023 Apr;
38(4):714-715.
PMID: 37061880
No abstract available.
9.
Ortega R, Bressman S, Raymond D, Ozelius L, Katsnelson V, Leaver K, et al.
Mov Disord
. 2022 Sep;
37(11):2217-2225.
PMID: 36054306
Background: Although men and women with the LRRK2 G2019S variant appear to be equally likely to have Parkinson's disease (PD), the sex-distribution among glucocerebrosidase (GBA) variant carriers with PD, including...
10.
Saunders-Pullman R, Ortega R, Wang C, Raymond D, Elango S, Leaver K, et al.
Neurology
. 2022 Aug;
99(8):e814-e823.
PMID: 35995594
Background And Objectives: There is clinical and phenotypic heterogeneity in G2019S Parkinson disease (PD), including loss of smell. Olfactory scores have defined subgroups of PD at baseline. We now extend...